BR0307243A - Processo para preparar propionato de fluticasona, e, composto - Google Patents
Processo para preparar propionato de fluticasona, e, compostoInfo
- Publication number
- BR0307243A BR0307243A BR0307243-6A BR0307243A BR0307243A BR 0307243 A BR0307243 A BR 0307243A BR 0307243 A BR0307243 A BR 0307243A BR 0307243 A BR0307243 A BR 0307243A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- fluticasone propionate
- preparing fluticasone
- preparing
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"PROCESSO PARA PREPARAR PROPIONATO DE FLUTICASONA, E, COMPOSTO". é descrito um processo para preparar propionato de fluticasona como Forma polimórfica cristalina 1, que compreende reagir um composto de fórmula (II) ou um seu sal com um composto de fórmula LCH2F, em que L representa um grupo de partida, opcionalmente na presença de um catalisador por transferência de fase, um solvente líquido, orgânico, não solvatante e imiscível em água e água.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0202564.1A GB0202564D0 (en) | 2002-02-04 | 2002-02-04 | Process |
PCT/EP2003/001115 WO2003066653A2 (en) | 2002-02-04 | 2003-02-03 | Process for the production of fluticasone propionate, in particular of polymorphic form 1 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0307243A true BR0307243A (pt) | 2004-12-14 |
Family
ID=9930366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0307243-6A BR0307243A (pt) | 2002-02-04 | 2003-02-03 | Processo para preparar propionato de fluticasona, e, composto |
Country Status (22)
Country | Link |
---|---|
US (1) | US20050222107A1 (pt) |
EP (1) | EP1474436B1 (pt) |
JP (1) | JP2005517019A (pt) |
KR (1) | KR20040086331A (pt) |
CN (1) | CN100338087C (pt) |
AR (1) | AR038390A1 (pt) |
AT (1) | ATE446965T1 (pt) |
AU (1) | AU2003206836B2 (pt) |
BR (1) | BR0307243A (pt) |
CA (1) | CA2473896A1 (pt) |
CO (1) | CO5611115A2 (pt) |
DE (1) | DE60329824D1 (pt) |
GB (1) | GB0202564D0 (pt) |
IS (1) | IS7373A (pt) |
MX (1) | MXPA04007530A (pt) |
NO (1) | NO327138B1 (pt) |
NZ (1) | NZ534320A (pt) |
PL (1) | PL372214A1 (pt) |
RU (1) | RU2333218C2 (pt) |
TW (1) | TW200410982A (pt) |
WO (1) | WO2003066653A2 (pt) |
ZA (1) | ZA200405826B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL153462A0 (en) * | 2002-12-16 | 2003-07-06 | Chemagis Ltd | Thiocarboxylic acid organic salts and processes utilizing the same |
PT2044099E (pt) * | 2006-06-14 | 2012-06-06 | Generics Uk Ltd | Processo de preparação s-fluorometil-6,9-difluoro-11- hidroxi-16-metil-17-propioniloxi-3-oxo-androsta-l,4- dieno-17-carbotioato e seus intermediários |
AU2013202835B2 (en) * | 2006-06-14 | 2015-11-12 | Generics [Uk] Limited | Process for the preparation of S-fluoromethyl-6,9-difluoro-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1, 4-diene-17-carbothioate and intermediates |
WO2012029077A2 (en) * | 2010-09-01 | 2012-03-08 | Cadila Healthcare Limited | Process for preparing fluticasone propionate/furoate |
JP2014520848A (ja) * | 2011-07-08 | 2014-08-25 | ファイザー・リミテッド | 1型プロピオン酸フルチカゾンの調製のための方法 |
CA2872845C (en) | 2012-05-08 | 2021-11-09 | Aciex Therapeutics, Inc. | Preparation of nanocrystals of fluticasone propionate |
US8765725B2 (en) | 2012-05-08 | 2014-07-01 | Aciex Therapeutics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
DE102012221219B4 (de) * | 2012-11-20 | 2014-05-28 | Jesalis Pharma Gmbh | Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel |
US9815865B2 (en) | 2013-01-07 | 2017-11-14 | Nicox Ophthalmics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2455976A1 (de) * | 1974-11-27 | 1976-08-12 | Merck Patent Gmbh | Prostensaeurederivate |
PH24267A (en) * | 1980-02-15 | 1990-05-29 | Glaxo Group Ltd | Androstane carbothioates and pharmaceutical compositions containing the same |
US5783677A (en) * | 1993-09-24 | 1998-07-21 | Procter & Gamble Pharmaceuticals, Inc. | Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds |
US5488188A (en) * | 1994-09-29 | 1996-01-30 | Merrell Dow Pharmaceuticals Inc. | Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, novel processes for preparing an intermediate thereof, and novel intermediates thereof |
GB9622173D0 (en) * | 1996-10-24 | 1996-12-18 | Glaxo Group Ltd | Particulate Products |
GB9925934D0 (en) * | 1999-11-03 | 1999-12-29 | Glaxo Group Ltd | Novel apparatus and process |
AP1422A (en) * | 2000-08-05 | 2005-06-05 | Glaxo Group Ltd | 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent. |
-
2002
- 2002-02-04 GB GBGB0202564.1A patent/GB0202564D0/en not_active Ceased
-
2003
- 2003-01-30 TW TW092102249A patent/TW200410982A/zh unknown
- 2003-01-31 AR ARP030100299A patent/AR038390A1/es not_active Application Discontinuation
- 2003-02-03 US US10/502,866 patent/US20050222107A1/en not_active Abandoned
- 2003-02-03 AT AT03704541T patent/ATE446965T1/de not_active IP Right Cessation
- 2003-02-03 PL PL03372214A patent/PL372214A1/xx unknown
- 2003-02-03 AU AU2003206836A patent/AU2003206836B2/en not_active Ceased
- 2003-02-03 CA CA002473896A patent/CA2473896A1/en not_active Abandoned
- 2003-02-03 JP JP2003566024A patent/JP2005517019A/ja active Pending
- 2003-02-03 EP EP03704541A patent/EP1474436B1/en not_active Expired - Lifetime
- 2003-02-03 DE DE60329824T patent/DE60329824D1/de not_active Expired - Fee Related
- 2003-02-03 WO PCT/EP2003/001115 patent/WO2003066653A2/en active Application Filing
- 2003-02-03 CN CNB038074370A patent/CN100338087C/zh not_active Expired - Fee Related
- 2003-02-03 BR BR0307243-6A patent/BR0307243A/pt not_active IP Right Cessation
- 2003-02-03 NZ NZ534320A patent/NZ534320A/en unknown
- 2003-02-03 KR KR10-2004-7011981A patent/KR20040086331A/ko not_active Application Discontinuation
- 2003-02-03 RU RU2004122928/04A patent/RU2333218C2/ru not_active IP Right Cessation
- 2003-02-03 MX MXPA04007530A patent/MXPA04007530A/es active IP Right Grant
-
2004
- 2004-07-21 ZA ZA200405826A patent/ZA200405826B/en unknown
- 2004-07-26 IS IS7373A patent/IS7373A/is unknown
- 2004-07-30 CO CO04074014A patent/CO5611115A2/es not_active Application Discontinuation
- 2004-09-01 NO NO20043664A patent/NO327138B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IS7373A (is) | 2004-07-26 |
KR20040086331A (ko) | 2004-10-08 |
NO327138B1 (no) | 2009-05-04 |
ZA200405826B (en) | 2005-08-11 |
AU2003206836B2 (en) | 2009-01-08 |
CO5611115A2 (es) | 2006-02-28 |
TW200410982A (en) | 2004-07-01 |
ATE446965T1 (de) | 2009-11-15 |
AU2003206836A1 (en) | 2003-09-02 |
PL372214A1 (en) | 2005-07-11 |
US20050222107A1 (en) | 2005-10-06 |
CN100338087C (zh) | 2007-09-19 |
WO2003066653A2 (en) | 2003-08-14 |
AR038390A1 (es) | 2005-01-12 |
CA2473896A1 (en) | 2003-08-14 |
NZ534320A (en) | 2007-07-27 |
EP1474436A2 (en) | 2004-11-10 |
EP1474436B1 (en) | 2009-10-28 |
MXPA04007530A (es) | 2004-11-10 |
WO2003066653A3 (en) | 2003-12-24 |
GB0202564D0 (en) | 2002-03-20 |
JP2005517019A (ja) | 2005-06-09 |
RU2333218C2 (ru) | 2008-09-10 |
CN1642969A (zh) | 2005-07-20 |
RU2004122928A (ru) | 2005-05-27 |
NO20043664L (no) | 2004-09-01 |
DE60329824D1 (de) | 2009-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0307243A (pt) | Processo para preparar propionato de fluticasona, e, composto | |
BR0306886A (pt) | Processos para a remoção de ácidos a partir de misturas da reação através de uma base auxiliar e para a preparação de compostos de fósforo a partir dos respectivos reagentes, e, usos de compostos, de um ligando e de um catalisador | |
BRPI0410238A (pt) | compostos orgánicos | |
BR0315439A (pt) | Processo para a manufatura de mercaptosilano bloqueado como agentes de ligação | |
BRPI0512060B8 (pt) | compostos orgânicos, composições farmacêuticas compreendendo os mesmos, bem como uso e processo de preparação dos referidos compostos | |
BR0109643A (pt) | Processo sintético e forma de cristal de derivados condensados da imidazopiridina | |
DE50111389D1 (de) | Phasentransfer von nanopartikeln | |
AR063415A1 (es) | Hidratos de clorhidrato de erlotinib para el tratamiento del cancer | |
BR9909739A (pt) | Benzotiadiazóis e derivados | |
BRPI0518958B8 (pt) | método para produzir um derivado de biopterina, 1;2'-0- diacetil-l-biopterina e l-biopterina | |
BRPI0507979A (pt) | processo para preparação de um composto | |
BR0103969A (pt) | Aparelho e processo para a preparação de fundidos de sal e seus usos | |
BRPI0407404A (pt) | processo para oxidação de alquil-benzenos para produzir hidroperóxidos | |
BRPI0504780A (pt) | compostos de benzotiadiazina, processo para sua preparação e composições farmacêuticas contendo os mesmos | |
ES2191943T3 (es) | Procedimiento de epoxidacion empleando un compuesto de peroxowolframato estabilizado con fosfato como catalizador. | |
BRPI0616169B8 (pt) | cloridrato de lercanidipina na forma polimorfa v, composição farmacêutica compreendendo dito composto e processos para preparação de cloridrato de lercanidipina | |
BR0110805A (pt) | Processo para a preparação de compostos de anilina | |
IT1319196B1 (it) | Sintesi dell'acido r(+)alfa-lipoico. | |
BR0009453A (pt) | Processo para a preparação de um composto | |
ES2187075T3 (es) | Metodo para producir isoureas. | |
AR029002A1 (es) | Proceso para preparar compuestos de acidos quinolin-2-carboxilicos y de sus sales farmaceuticamente aceptables | |
AR043037A1 (es) | Benzo [1,2,5] tiadiazoles y su uso farmaceutico | |
AR062676A1 (es) | Procedimiento mejorado para preparar compuestos de pirrolidina 1,3-disustituidas | |
AR029431A1 (es) | Proceso para la preparacion de alfa-(2,4-disulfofenil)-n-ter-butilnitronas | |
BRPI0504124A8 (pt) | Processo para preparação de 7-cloro-1-[2-(dietilamino)etil]-5-(2-fluorofenil)-1,3-dihidro-2h-1,4-benzodiazepin-2-ona |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A(S) 8A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2112 DE 28/06/2011. |